Form 4: Eli Lilly Executive Anat Hakim Reports Stock Transactions

Anat Hakim, an executive at Eli Lilly, reported the acquisition of 4,442 shares of common stock through the vesting of restricted stock units and the disposal of 1,967 shares to cover tax obligations.

Summary

• Anat Hakim, an Executive Vice President, General Counsel & Secretary at Eli Lilly & Co, filed a Form 4 disclosing recent transactions in the company's stock.
• On February 1, 2024, Hakim acquired 4,442 shares of common stock through the vesting of restricted stock units.
• Also on February 1, 2024, Hakim disposed of 1,967 shares of common stock at a price of $645.61 per share to satisfy tax obligations related to the vesting of the restricted stock units.
• Following these transactions, Hakim directly owns 24,664 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected, reflecting standard executive compensation practices. The continued ownership of a significant number of shares by the executive is a positive sign.

Positives

• The vesting of restricted stock units indicates a positive performance incentive for the executive.
• The executive's continued direct ownership of 24,664 shares demonstrates a continued stake in the company's success.

Industry Context

This is a routine filing for executive stock transactions and is common practice for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and Eli Lilly's filing is consistent with these requirements.
• The vesting of restricted stock units and subsequent sale for tax obligations is a common form of executive compensation across the pharmaceutical industry, similar to practices at companies like Pfizer and Merck.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they are related to executive compensation and do not represent a significant change in the company's overall ownership structure.

Key Dates

Keywords

Form 4, insider trading, stock transaction, restricted stock units, executive compensation, Eli Lilly, LLY, Anat Hakim